Intravacc
Intravacc, based in the Netherlands within the Utrecht Science Park in Bilthoven, is a globally recognized leader in translational vaccinology. With over 100 years of experience, they serve as an independent Contract Development and Manufacturing Organization (CDMO) in the vaccine industry. Their mission is to bridge discoveries and early-stage clinical trials, mitigating risks and reducing costs in vaccine development.
Industries
Nr. of Employees
medium (51-250)
Intravacc
Patents
Products
Outer membrane vesicle (OMV) vaccine platform
A platform using outer membrane vesicles for antigen presentation and vaccine formulation for infectious disease and oncology indications.
Vero cell–based vaccine production platform
A platform using a Vero GMP cell line for reliable large-scale production of viral vaccines.
Conjugate vaccine development platform
Platform focused on conjugation methods and design for cost-effective conjugate vaccines.
E. coli recombinant protein expression platform
Bacterial expression system platform for rapid and cost-effective production of recombinant proteins used as vaccine antigens.
Outer membrane vesicle (OMV) vaccine platform
A platform using outer membrane vesicles for antigen presentation and vaccine formulation for infectious disease and oncology indications.
Vero cell–based vaccine production platform
A platform using a Vero GMP cell line for reliable large-scale production of viral vaccines.
Conjugate vaccine development platform
Platform focused on conjugation methods and design for cost-effective conjugate vaccines.
E. coli recombinant protein expression platform
Bacterial expression system platform for rapid and cost-effective production of recombinant proteins used as vaccine antigens.
Services
Contract development and manufacturing services to advance vaccine candidates from discovery to early clinical material supply.
Upstream and downstream process development to enable reproducible, scalable vaccine manufacturing.
Development of analytical assays and methods to characterize vaccine components and support quality control.
GMP-compliant production of clinical- and commercial-grade vaccine material.
Contract development and manufacturing services to advance vaccine candidates from discovery to early clinical material supply.
Upstream and downstream process development to enable reproducible, scalable vaccine manufacturing.
Development of analytical assays and methods to characterize vaccine components and support quality control.
GMP-compliant production of clinical- and commercial-grade vaccine material.
Expertise Areas
- Translational vaccinology and clinical translation
- Vaccine platform development
- Bioprocess development and scale-up
- GMP vaccine manufacturing
Key Technologies
- Outer membrane vesicles (OMV)
- Vero cell–based viral vaccine production
- Conjugation chemistry for conjugate vaccines
- E. coli recombinant protein expression
News & Updates
Over 100 Years of Experience
Intravacc has over a century of experience in vaccine development.
Global Customer Base
Serves over 50 customers worldwide.
Scientific Publications
Published over 300 scientific articles.
State-of-the-art Facilities
Operates with more than 2000 square meters of advanced facilities.
Over 100 Years of Experience
Intravacc has over a century of experience in vaccine development.
Global Customer Base
Serves over 50 customers worldwide.
Scientific Publications
Published over 300 scientific articles.
State-of-the-art Facilities
Operates with more than 2000 square meters of advanced facilities.